MeSH D006976 - pulmonary hypertension
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Nitroglycerin | Rectiv |  | 2011-06-21 |  |  |
| Accord Healthcare | Sildenafil | Granpidam |  | 2016-11-14 |  |  |
| Tadalafil | Tadalafil |  | 2019-03-26 |  |  | |
| Actelion | Macitentan | Opsumit | 2025-12-05 | 2013-10-18 |  |  |
| Bosentan | Tracleer |  | 2001-11-20 |  |  | |
| Selexipag | Uptravi | 2026-10-31 | 2015-12-21 |  |  | |
| Epoprostenol | Veletri | 2027-02-02 | 2008-06-27 |  |  | |
| Iloprost | Ventavis |  | 2004-12-29 |  |  | |
| Ajanta Pharma | Sildenafil | Sildenafil |  | 2018-10-12 |  |  |
| Tadalafil | Tadalafil |  | 2019-03-26 |  |  | |
| Alembic Pharmaceuticals | Bosentan | Bosentan |  | 2020-01-23 |  |  |
| Tadalafil | Tadalafil |  | 2019-03-26 |  |  | |
| Selexipag | Selexipag |  | 2023-10-11 |  |  | |
| Treprostinil | Treprostinil |  | 2021-02-11 |  |  | |
| Macitentan | Macitentan |  | 2025-08-18 |  |  | |
| Alkem Laboratories | Hydralazine | Hydralazine |  | 2012-12-07 |  |  |
| Sildenafil | Sildenafil |  | 2019-11-27 |  |  | |
| Allergan | Ambrisentan | Ambrisentan |  | 2019-03-28 |  |  |
| Bosentan | Bosentan |  | 2019-04-26 |  |  | |
| Hydralazine | Hydralazine |  | 1982-01-01 |  |  | |
| Hydrochlorothiazide, Hydralazine | Hydralazine Hydrochlorothiazide |  | 1982-03-04 |  |  | |
| Hydrochlorothiazide, Hydralazine, Reserpine | Hydralazine, Hydrochlorothiazide W/ Reserpine |  | 1982-01-01 |  |  | |
| Hydrochlorothiazide, Hydralazine | Hydrochlorothiazide W/ Hydralazine |  | 1982-01-01 |  |  | |
| Hydrochlorothiazide, Hydralazine, Reserpine | Hydrochlorothiazide W/ Reserpine Hydralazine |  | 1982-01-01 |  |  | |
| Nitroglycerin | Nitroglycerin |  | 2017-10-16 |  |  | |
| Hydrochlorothiazide, Hydralazine, Reserpine | Reserpine, Hydralazine Hydrochlorothiazide |  | 1982-01-01 |  |  | |
| Sildenafil | Sildenafil |  | 2013-02-25 |  |  | |
| Sildenafil | Sildenafil Actavis |  | 2009-12-10 |  |  | |
| Tadalafil | Tadalafil |  | 2019-03-29 |  |  | |
| Alvogen | Bosentan | Bosentan |  | 2019-04-26 |  |  |
| American Regent | Hydralazine | Hydralazine |  | 1997-06-30 |  |  |
| Nitroglycerin | Nitroglycerin |  | 1988-05-24 |  |  | |
| Amneal Pharmaceuticals | Bosentan | Bosentan |  | 2019-04-26 |  |  |
| Sildenafil | Sildenafil |  | 2018-06-27 |  |  | |
| Tadalafil | Tadalafil |  | 2019-03-26 |  |  |
1
2
3
4
5
6
...
11
>
Clinical Trials
Historical Success Rate
Phase 1
54%19/35
Phase 2
40%20/50
Phase 3
75%41/55
Approved: 24Overall Success rate: 16%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
7
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use